Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0
| Title: | Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 |
|---|---|
| Contributors: | Caturano, Alfredo |
| Publisher Information: | MDPI - Multidisciplinary Digital Publishing Institute, 2024. |
| Publication Year: | 2024 |
| Subject Terms: | calcification, inflammation, osteopontin, carotid stenosis, carotid endarterectomy, thyroid hormone, thyroid receptors, low T3 syndrome, heart failure, coronary disease, cardiac remodeling, cardiovascular surgery patients, aortic aneurism, aortic dissection, aromatic microbial metabolites, tyrosine metabolites, 4-hydroxyphenyllactic acid, infectious complications, atrial fibrillation, electrical cardioversion, post-procedural complications, biomarkers, fibroblast growth factor 23, two-dimensional speckle-tracking echocardiography, left ventricular diastolic dysfunction, diabetes mellitus, lipoprotein(a), children, adolescents, cardiovascular risk, cardiovascular disease, diet, herbs, pharmaceutical drugs, remodeling, myocardial infarction, cardiac macrophages, kidney macrophages, sodium/glucose cotransporter 2 (SGLT2) inhibitors, bexagliflozin, cardiovascular diseases, conventional risk factors, cardiovascular prevention, emerging risk factors, handgrip, metabolic syndrome, blood pressure, isometric strength, vascular stiffness, muscle strength dynamometer, treatment, real-life, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonist, orthotopic heart transplantation (OHT), transcatheter aortic valve implantation (TAVI), heart valve replacement, aortic valve, obesity hypoventilation syndrome, obstructive sleep apnea, CPAP, noninvasive ventilation, NIV adherence, cognitive training, multi-tasking, postoperative cognitive dysfunction, cardiac surgery, fatty liver index, orthotopic liver transplantation, stroke, PCSK9, PCSK9 inhibitor, evolocumab, women’s health, cardiovascular, echocardiography, sleep apnea, adenotonsillectomy, exosomal RNA sequencing, exosome, acute myocardial infarction, microRNA, cardiac tissue, platelet, proteomics, CVDs, cancer, transfusion, Medicine and Nursing, Pharmacology |
| More Details: | Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, with an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Heart attacks and strokes accounted for approximately 85% of these fatalities The prevalence of CVDs is worsened by metabolic diseases, particularly diabetes, which affects about 422 million people globally, primarily in low- and middle-income countries, and causes 1.5 million deaths annually. Early detection and intervention of CVDs and metabolic diseases are crucial, as many cases can be prevented by addressing modifiable behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity, and harmful alcohol consumption. Significant advancements in treatment, from pharmacological developments to both invasive and non-invasive techniques, are continuously being made. Given the complexity and clinical significance of this topic, Biomedicines is proud to present a Special Issue titled "Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0". This issue aims to compile contemporary scientific information on emerging treatments for CVDs and metabolic diseases. They provide valuable insights to the field and enhance our understanding of these interconnected health challenges. |
| Document Type: | eBook |
| File Description: | application/octet-stream |
| Language: | English |
| ISBN: | 978-3-7258-1667-5 978-3-7258-1668-2 |
| DOI: | 10.3390/books978-3-7258-1668-2 |
| Access URL: | https://directory.doabooks.org/handle/20.500.12854/143821 https://mdpi.com/books/pdfview/book/9573 |
| Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International open access URL: http://purl.org/coar/access_right/c_abf2 URL: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Notes: | ONIX_20240906_9783725816675_183 |
| Accession Number: | edsdob.20.500.12854.143821 |
| Database: | Directory of Open Access Books |
| ISBN: | 9783725816675 9783725816682 |
|---|---|
| DOI: | 10.3390/books978-3-7258-1668-2 |
| Language: | English |